Kodiak Sciences to Present at the Evercore ISI 5th Annual HealthCONx Conference
PALO ALTO, Calif., Nov. 16, 2022 /PRNewswire/ --Kodiak Sciences Inc. (NASDAQ: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on Tuesday, November 29, 2022, at 9:10am Pacific Time (12:10pm Eastern Time).